← Back to Rankings

JBHTJ.B. Hunt Transport Services, Inc.

Fundamentals Score: 59.4/100 (Fair Fundamentals) · Industrials

Description

Operating across North America, J.B. Hunt Transport Services, Inc. specializes in ground transportation, last-mile delivery, and comprehensive logistics solutions.

Score Breakdown

Growth
58.3/100
weight: 45%
Quality / Profitability
53.4/100
weight: 40%
Financial Health
78.6/100
weight: 15%
Valuation Context (informational only — not part of the score)
Rich vs. its own history
Entry Timing (informational only — not part of the score)
Neutral

Live Market DataPrice updated: 3h ago

P/E (TTM)
37.8
Yield
0.67%
RSI (14)
47.4
vs SMA20
-0.95%
vs SMA50
-3.64%
vs SMA200
+12.43%
Analyst Target
$298
+11.9%
20 analysts
AI Theoretical Price
$235
-11.7%
as of 2026-08-27

AI Deep-Dive Analysis

Analysis as of 2026-08-27 - price/technical figures below reflect that date, not live market data

As of 2026-08-27, JBHT trades at $263.39, roughly 12% below its 52-week high of $299.76. Q2 2026 was a strong beat (EPS $1.91 vs $1.71 consensus, revenue +19.4% YoY), but the stock sits below its 20- and 50-day moving averages with RSI at 41.4.

AI Sentiment:Bullish

Market sentiment is constructive after Q2 2026 revenue grew 19.4% YoY, operating income rose 32%, and EPS grew 45.8%. The analyst consensus is Buy with a $298.33 average price target, and 60-day EPS estimate revisions for 2026/2027 have been lifted roughly 6.5-8.5%. The late-August freight-sector pullback has taken price off the high, but the dominant narrative remains a recovering freight cycle.

Quarterly Trend

The trend is inflecting upward, not just a one-off beat. Revenue went from roughly flat YoY in 2025 quarters to $3.50B in Q2 2026, up 19.4% versus Q2 2025. Operating income improved from $197.3M in Q2 2025 to $259.5M in Q2 2026 (+31.5%), and EPS rose from $1.31 to $1.91. Operating margin expanded from ~6.7% to ~7.4% YoY, with Q4/Q3 2025 also running near 8.0%. Full-year EPS has gone from ~$5.56 (2024) to ~$6.14 (2025) to a consensus ~$7.84 (2026), so the recovery is broad-based rather than a blip.

Valuation Assessment

Expensive versus its own history. As of 2026-08-27, TTM P/E is 37.4x and P/S is 1.95x versus 5-year averages of 27.5x and 1.52x. On the forward consensus EPS of $7.84, P/E is still ~33.6x, and PEG is 1.39. That is a premium valuation that already assumes a durable freight upcycle and continued earnings growth.

Price vs. Earnings Playbook

The price is discounting earnings that haven't fully shown up in the TTM numbers yet. TTM EPS is $7.10, but $263.39 divided by JBHT's 5-year average P/E of 27.5x implies ~$9.58 of EPS. In other words, the market is effectively pricing a strong 2027 outcome today. If 2026-2027 estimates keep rising, the stock can grow into the multiple; if the peak-season recovery disappoints, the multiple is vulnerable.

Technical Picture

As of 2026-08-27, RSI-14 is 41.4 — neutral, not oversold. Price is 2.8% below the 20-day SMA and 5.0% below the 50-day SMA, but 12.3% above the 200-day SMA. The long-term uptrend is intact, but short-term momentum is in a pullback/consolidation phase. A reclaim of the 50-day or an RSI dip to oversold would be a more attractive technical entry than buying here.

Macro Factors
  • Freight cycle is inflecting: truckload capacity is tightening, rail service has improved, and intermodal conversion is picking back up.
  • Interest rates and capital costs still matter for a 1.3-beta, capex-heavy logistics company; rate expectations drive multiple compression/expansion.
  • Purchased transportation, fuel, and driver/equipment costs can swing margins; Q2 2026 showed discipline on this front.
  • Consumer/industrial freight demand and peak-season strength will determine whether the recovery broadens into 2027.
Key Catalysts
  • Q3 2026 earnings (expected mid-October 2026): peak-season intermodal volumes and truckload pricing commentary.
  • Monthly Cass/freight data confirming sustained volume and pricing recovery.
  • Upward estimate revisions and any further price-target increases from analysts.
  • Continued buyback execution (~$791M remaining under authorization) supporting EPS.
Key Risks
  • Freight recovery stalls or the economy rolls over, reversing volume and pricing gains.
  • Valuation compression: from ~37x TTM / ~34x forward P/E back toward the 5-year average would hit the stock hard.
  • Rail service or network disruption undermines intermodal's cost/service advantage.
  • Cost inflation (purchased transportation, equipment, driver pay) outrunning pricing power.
Investment Thesis

JBHT is a high-quality, financially sound logistics leader and the Q2 2026 numbers confirm the freight cycle has turned in its favor. However, at $263.39 the market has already paid a premium for that recovery, so the risk/reward is balanced rather than compelling. I'd want a pullback closer to my fair-value estimate or fresh evidence that 2027 estimates are still being revised upward before calling this a clear buy.

AI Theoretical Price Methodology

Used a 30.0x forward P/E multiple on the latest consensus EPS estimate of $7.84, a modest ~2.5-turn premium to JBHT's 5-year average P/E of 27.5x to reflect the confirmed cyclical recovery and upward estimate revisions. This yields $235.08, below the $263.39 market price, consistent with the 'Rich vs. its own history' valuation label.

AI Lean: NeutralConfidence: Medium

AI Review of the Deterministic Score

Agree

The deterministic 59.4 'Fair Fundamentals' score is a fair read. Trailing data already capture the Q2 2026 inflection (19.4% revenue growth, 45.8% EPS growth), quality is moderate (TTM operating margin ~7.5%, ROIC 9.3%), and the balance sheet is solid with a negative accruals ratio and positive recent free cash flow. I would nudge the score a few points higher because the formula is backward-looking and the live freight-cycle recovery plus upward revisions suggest forward strength, but not enough to move the band — the stock still has high valuation and only mid-single-digit net margins. So: Agree, with a slight upward tilt.

AI-generated analysis for informational purposes only, not financial advice.